Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan
· Delayed Price · Currency is TWD
Full Chart
Watchlist
Compare
38.45
-0.20 (-0.52%)
May 29, 2026, 1:49 PM CST
Overview
Financials
Statistics
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Semi-Annual
TTM
TPEX:7427 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Mil
Millions
Data
Data Source
TWD
TWD
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
Net Income
-97.47
-104.92
-61
-67.13
-35.86
Depreciation & Amortization
7.62
6.9
4.28
1.76
1.44
Other Amortization
0.07
0.04
0.07
0.06
0.06
Loss (Gain) From Sale of Assets
-
-
-0.12
-
-
Stock-Based Compensation
11.16
14.97
11.29
4.91
3.66
Other Operating Activities
0.1
0.13
0.09
-0.01
-0.03
Change in Accounts Receivable
0.65
-0.62
-0.09
-
-0.04
Change in Inventory
-4.28
3.15
-6.16
-
-
Change in Accounts Payable
-2.95
6.61
1.05
-
-
Change in Other Net Operating Assets
-2.44
-3.09
-4.4
-16.76
-3.15
Operating Cash Flow
-87.56
-76.85
-54.99
-77.17
-33.92
Capital Expenditures
-0.28
-2.11
-2.93
-0.05
-0.04
Sale of Property, Plant & Equipment
-
-
0.12
-
-
Sale (Purchase) of Intangibles
-3.21
-1.36
-16.29
-1.18
-27.97
Investment in Securities
10
-130.7
-160.5
-74.19
-62.32
Other Investing Activities
2.86
0.68
-3.18
-2.45
-
Investing Cash Flow
9.37
-133.49
-182.78
-77.85
-90.32
Long-Term Debt Repaid
-3
-3
-1.25
-
-
Net Debt Issued (Repaid)
-3
-3
-1.25
-
-
Issuance of Common Stock
0.94
188.84
307.49
203.31
120
Repurchase of Common Stock
-44.97
-
-
-
-
Financing Cash Flow
-47.03
185.84
306.24
203.31
120
Net Cash Flow
-125.22
-24.49
68.47
48.29
-4.24
Free Cash Flow
-87.84
-78.96
-57.92
-77.21
-33.96
Free Cash Flow Margin
-7289.46%
-4685.82%
-1194.21%
-14298.70%
-5389.68%
Free Cash Flow Per Share
-2.04
-1.92
-1.60
-3.20
-1.61
Levered Free Cash Flow
-52.5
-53.21
-48.79
-50.61
-29.53
Unlevered Free Cash Flow
-52.44
-53.14
-48.73
-50.61
-29.53
Change in Working Capital
-9.03
6.04
-9.6
-16.76
-3.19